Emilien DUGRAND

EMILIEN DUGRAND, PharmD

Technical Analyst

Emilien is responsible for the evaluation of new technologies and products.

Prior to Ginward, Emilien accumulated professional experiences in the health sector. Among his key experiences, Emilien worked at Servier Laboratories as a business developer in the Oncology Business Unit of the French subsidiary and in the Sales and Operations Department. He was a Self-Entrepreneur for one year in Paris, where he carried out operational consulting missions for both e-health start-ups and consumer healthcare laboratories. Emilien has an in-depth knowledge of city pharmacies and the hospital sector.

Emilien holds a PharmD in Pharmacy from the University of Montpellier in France, with a specialization in Industrial Pharmacy. His thesis in 2018 focused on access to the CAR-T cell therapy market in France.  In September 2019, he joined a Master of Science in Strategy and Management programme in International Business from ESSEC Business School in Singapore.

Emilien is native in French, fluent in English, and intermediate in Spanish

Edward Willems

EDWARD WILLEMS

Managing Director & Co-founder

Ginger Hsiao

GINGER HSIAO

Co-founder

Shang Hsiao

SHANG HSIAO, JD, CPA

Co-founder and Venture Partner

HA LINH NGUYEN, PhD

Technical Analyst

BERT TJEENK WILLINK, MD

Advisor and Venture Partner

NAO YOSHIZAWA

Advisor

KOUHEI TSUMOTO, PhD

Scientific Advisor

Andrew Lin

ANDREW LIN, MBA

Advisor

Clark Su

CLARK SU, MBA

Advisor

Adam Kirby

ADAM KIRBY

Advisor

Jerry Hong

JERRY HONG

Advisor